Estimating complex multi-state misclassification rates for biopsy-measured liver fibrosis in patients with hepatitis C

International Journal of Biostatistics

Volumn 5, Issue 1, 2009, Pages

  Bacchetti, Peter ^a   Boylan, Ross ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fibrosis; Hepatitis C; Kappa statistic; Latent variables; Misclassification

Indexed keywords

ARTICLE; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; HEPATITIS C; HUMAN; KAPPA STATISTICS; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HISTOLOGY; MISCLASSIFICATION RATE; RATING SCALE; SAMPLING ERROR; BIOPSY; CLASSIFICATION; EPIDEMIOLOGY; PATHOLOGY; STANDARD; STATISTICAL MODEL;

HEPATITIS C VIRUS;

BIOPSY; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MODELS, STATISTICAL; SELECTION BIAS;

EID: 62549148602     PISSN: 15574679     EISSN: None     Source Type: Journal    
DOI: 10.2202/1557-4679.1139     Document Type: Article

References (27)

1. Albert, P. S., and Dodd, L. E. (2004). A cautionary note on the robustness of latent class models for estimating diagnostic error without a gold standard. Biometrics 60, 427-435.
2. Albert, P. S., Hunsberger, S. A., and Biro, F. M. (1997). Modeling repeated measures with monotonic ordinal responses and misclassification, with applications to studying maturation. Journal of the American Statistical Association 92, 1304-1311.
3. Bacchetti, P., Tien, P. C., Seaberg, E. C., et al. (2007). Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression. BMC Infectious Diseases 7, 145.
4. Batts, K. P., and Ludwig, J. (1995). Chronic hepatitis - an update on terminology and reporting. American Journal of Surgical Pathology 19, 1409-1417.
5. Bedossa, P., Bioulacsage, P., Callard, P., et al. (1994). Intraobserver and interobserver variations in liver-biopsy interpretation in patients with chronic hepatitis-C. Hepatology 20, 15-20.
6. Bissell, D. M. (2004). Assessing fibrosis without a liver biopsy: Are we there yet? Gastroenterology 127, 1847-1849.
7. Cross, T., Antoniades, C., and Harrison, P. (2008). Non-invasive markers for the prediction of fibrosis in chronic hepatitis C infection. Hepatology Research 38, 762-769.
8. Deuffic-Burban, S., Poynard, T., and Valleron, A. J. (2002). Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model. Journal of Viral Hepatitis 9, 114-122.
9. Evans, M., and Swartz, T. (1995). Methods for approximating integrals in statistics with special emphasis on Bayesian integration problems. Statistical Science 10, 254-272.
10. Gentleman, R. C., Lawless, J. F., Lindsey, J. C., and Yan, P. (1994). Multistate Markov-models for analyzing incomplete disease history data with illustrations for HIV disease. Statistics in Medicine 13, 805-821.
11. Hui, S. L., and Walter, S. D. (1980). Estimating the error rates of diagnostic-tests. Biometrics 36, 167-171.
12. Jackson, C. H., and Sharples, L. D. (2002). Hidden Markov models for the onset and progression of bronchiolitis obliterans syndrome in lung transplant recipients. Statistics in Medicine 21, 113-128.
13. Jackson, C. H., Sharples, L. D., Thompson, S. G., Duffy, S. W., and Couto, E. (2003). Multistate Markov models for disease progression with classification error. Journal of the Royal Statistical Society Series D-the Statistician 52, 193-209.
14. Kalbfleisch, J. D., and Lawless, J. F. (1985). The analysis of panel data under a Markov assumption. Journal of the American Statistical Association 80, 863-871.
15. Kay, R. (1986). A Markov model for analyzing cancer markers and disease states in survival studies. Biometrics 42, 855-865.
16. Manning, D. S., and Afdhal, N. H. (2008). Diagnosis and quantitation of fibrosis. Gastroenterology 134, 1670-1681.
17. Mwalili, S. M., Lesaffre, E., and Declerck, D. (2008). The zero-inflated negative binomial regression model with correction for misclassification: an example in caries research. Statistical Methods in Medical Research 17, 123-139.
18. Netto, G. J., Watkins, D. L., Williams, J. W., et al. (2006). Interobserver agreement in hepatitis C grading and staging and in the Banff grading schema for acute cellular rejection - The "Hepatitis C 3" multi-institutional trial experience. Archives of Pathology & Laboratory Medicine 130, 1157-1162.
19. Parkes, J., Guha, I. N., Roderick, P., and Rosenberg, W. (2006). Performance of serum marker panels for liver fibrosis in chronic hepatitis C. Journal of Hepatology 44, 462-474.
20. Pepe, M. S., and Janes, H. (2007). Insights into latent class analysis of diagnostic test performance. Biostatistics 8, 474-484.
21. Regev, A., Berho, M., Jeffers, L. J., et al. (2002). Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. American Journal of Gastroenterology 97, 2614-2618.
22. Rousselet, M. C., Michalak, S., Dupre, F., et al. (2005). Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 41, 257-264.
23. Satten, G. A., and Longini, I. M. (1996). Markov chains with measurement error: Estimating the 'true' course of a marker of the progression of human immunodeficiency virus disease. Applied Statistics-Journal of the Royal Statistical Society Series C 45, 275-295.
24. Skripenova, S., Trainer, T. D., Krawitt, E. L., and Blaszyk, H. (2007). Variability of grade and stage in simultaneous paired liver biopsies in patients with hepatitis C. Journal of Clinical Pathology 60, 321-324.
25. Stram, D. O., and Lee, J. W. (1994). Variance-components testing in the longitudinal mixed effects model. Biometrics 50, 1171-1177.
26. Terrault, N., Im, K., Boylan, R., et al. (2008). Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C. Clinical Gastroenterology and Hepatology 6, 1403-1411.
27. Vickers, A. J., and Elkin, E. B. (2006). Decision curve analysis: A novel method for evaluating prediction models. Medical Decision Making 26, 565-574.